Fresenius Medical Care North America
920 Winter Street, Waltham, MA, 02451, United States
Overview
Fresenius Medical Care North America is a hospital and health care company that focuses on providing healthcare services to people with renal and other chronic conditions. It offers dialysis facilities, outpatient cardiac and vascular labs, and urgent care centers. Fresenius Medical Care North America (FMCNA) is one of the largest providers of dialysis products and services. It has raised a record amount of money to support the goals and initiatives of the National Kidney Foundation (NKF) over the course of a two-year partnership. Fresenius Medical Care North America was founded in 1996 by Bill Valle and it is headquartered in Waltham, Massachusetts.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 8
Sector focus
- Biotechnology
- Health Care
- Medical
- Medical Device
- Pharmaceutical
Investment portfolio
- BioIntelliSense
Participated · Series B · Jul 2021
BioIntelliSense, led by CEO James Mault, MD, offers continuous health monitoring and clinical intelligence for Remote Patient Monitoring through medical-grade wearable devices and an advanced Data-as-a-Service (DaaS) platform. The platform captures multi-parameter vital signs, physiological biometrics, and symptomatic events to deliver high-resolution patient trending and reporting. Its FDA-cleared BioSticker™ and medical-grade BioButton® enable simple remote monitoring and early detection. Advanced analytics on the platform give clinicians access to actionable, medical-grade data to enable care at home. The company says it will use new funds to support continued growth and global expansion of its wearable devices and data services for scalable remote care. The business is based in Denver, Colorado.